Intellipharmaceutics International Inc. IPCIF
0.15 +0.15
Day range unavailable
52-week range unavailable
IPCIF revenue history
Revenue is income from the company’s ordinary business activities.
1,712,731 USD
FY 2018 · Period ended
Coverage: stale. Values in USD; not inflation adjusted.
Some periods have no fiscal period label and are omitted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2018 | 2018-11-30 | 1,712,731 | -3,791,721 | -68.88% |
| FY 2017 | 2017-11-30 | 5,504,452 | 3,257,450 | 144.97% |
| FY 2016 | 2016-11-30 | 2,247,002 | -1,846,779 | -45.11% |
| FY 2015 | 2015-11-30 | 4,093,781 | -4,675,912 | -53.32% |
| FY 2014 | 2014-11-30 | 8,769,693 | 7,242,219 | 474.13% |
| FY 2013 | 2013-11-30 | 1,527,474 | 1,420,383 | 1326.33% |
| FY 2012 | 2012-11-30 | 107,091 | -394,723 | -78.66% |
| FY 2011 | 2011-11-30 | 501,814 | -957,571 | -65.61% |
| FY 2010 | 2010-11-30 | 1,459,385 | 829,206 | 131.58% |
| FY 2009 | 2009-11-30 | 630,179 | -647,525 | -50.68% |
| FY 2008 | 2008-11-30 | 1,277,704 | -1,019,612 | -44.38% |
| FY 2007 | 2007-11-30 | 2,297,316 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2025-01-04T21:03:09.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.